Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.
Eligible Conditions
- Polyarteritis Nodosa
- Churg-Strauss Syndrome
- Giant Cell Arteritis
- Wegener's Granulomatosis
- Microscopic Polyangiitis
- Takayasu Arteritis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,053 Previous Clinical Trials
43,012,127 Total Patients Enrolled
9 Trials studying Polyarteritis Nodosa
2,799 Patients Enrolled for Polyarteritis Nodosa
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
493 Previous Clinical Trials
1,088,430 Total Patients Enrolled
5 Trials studying Polyarteritis Nodosa
5,247 Patients Enrolled for Polyarteritis Nodosa
Office of Rare Diseases (ORD)NIH
43 Previous Clinical Trials
11,329 Total Patients Enrolled
3 Trials studying Polyarteritis Nodosa
1,197 Patients Enrolled for Polyarteritis Nodosa
Share this study with friends
Copy Link
Messenger